+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dry Eye Drug"

From
From
Ophthalmic Drugs - Global Strategic Business Report - Product Thumbnail Image

Ophthalmic Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 478 Pages
  • Global
From
Ophthalmic Drugs Market Report 2025 - Product Thumbnail Image

Ophthalmic Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Artificial Tears - Global Strategic Business Report - Product Thumbnail Image

Artificial Tears - Global Strategic Business Report

  • Report
  • April 2025
  • 277 Pages
  • Global
From
From
From
Dry Eye Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Dry Eye Disease - Pipeline Insight, 2025

  • Clinical Trials
  • March 2025
  • 180 Pages
  • Global
From
From
From
From
From
From
From
Loading Indicator

The Dry Eye Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Dry Eye Drugs are used to treat the symptoms of dry eye syndrome, a condition in which the eyes do not produce enough tears or the tears evaporate too quickly. These drugs can be administered topically, orally, or through injection. Commonly used Dry Eye Drugs include artificial tears, anti-inflammatory medications, and immunomodulators. Some companies in the Dry Eye Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, Shire, and Sun Pharmaceuticals. Show Less Read more